Alliance Global Partners analyst Aaron Grey downgraded Flora Growth to Neutral from Buy without a price target. The company’s Q2 results were below estimates, as competition in the CBD market continued and Flora exited low-margin sales, the analyst tells investors in a research note. The firm cites uncertainty within the existing business for the downgrade.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLGC: